TBTiago Beirão

Tiago Beirão

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tiago Beirão has a total of 101 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Tracking the Path of Migratory Pain: Unveiling Whipple Disease

    by Tiago Beirão, Luis Gomes, Catarina Silva, Catarina Rua, Mariana Patela, Margarida Caldas, David João, Flavio Costa, Patricia Pinto, Romana Vieira, et al.

    Whipple’s disease (WD), a rare systemic infection caused by Tropheryma whipplei, often presents diagnostic challenges due to its nonspecific and varied clinical manifestations. We report the case of a woman initially diagnosed with undifferentiated connective tissue disease, who later developed severe malabsorptive symptoms, including steatorrhea and weight loss. Imaging revealed mesenteric lymphadenopathy, while histopathology and polymerase chain reaction (PCR) confirmed WD. Treatment included intravenous ceftriaxone followed by prolonged oral cotrimoxazole, leading to significant clinical improvement. However, persistent histological abnormalities warranted extended therapy. This case highlights the importance of considering infectious etiologies in atypical rheumatologic presentations, the role of molecular diagnostics in confirming WD, and the necessity of a multidisciplinary approach. Early recognition and appropriate management are critical to improving outcomes in this elusive disease.


  • Open Access

    Infection—key in treating hypothermia?

    by Tiago Beirão, Guilherme Jesus, Inês Pinto Pereira, Milton Severo, Joana Cochicho

    Aim of the study: Hypothermia as the major clinical feature at emergency admission poses a low-frequency yet complex and life-threatening challenge. Limited knowledge about its morbidity, mortality, and influencing factors contributes to the absence of standardized guidelines for rewarming treatments. This retrospective study, the first of its kind in Portugal, aims to fill this gap by examining hypothermic patients in a temperate climate, exploring rewarming treatments, mortality factors, and complications. Methods: Conducted at the Emergency Department of Centro Hospitalar Vila Nova de Gaia/Espinho, the study spanned from January 2008 to December 2020. Sixty-two patients with body temperatures below 35ºC were included. Data collection focused on patient background, clinical presentation, hypothermia mechanism, reperfusion treatment, and laboratory results. Clinical infection was defined based on symptoms and imaging findings. Results: The study revealed a diverse cohort, with an average age of 82 and a mortality rate of 33.9%. Clinical infection was prevalent in 51.6% of patients, mostly respiratory (59.4%). Rewarming treatments varied, and no specific method showed significant advantage. Complications included rhabdomyolysis, and late deaths were primarily attributed to infectious diseases, particularly pneumonia. Conclusions: Taking into account its high mortality rate, accidental hypothermia, demands further research and multicenter data collection for evidence-based treatment strategies. Clinical infection emerged as a significant factor in mortality, prompting a call for increased attention to infectious disease identification and treatment during hypothermic episodes.

  • Drugs and ANCA – an atypical association

    by T Beirão, B Samões, C Rua, R Vieira, J Abelha-Aleixo, P Pinto, F Costa, D Fonseca, M Mota, C Amorim Merileres, et al.

    Drugs and ANCA – an atypical association

  • Open Access

    Predictors of Interstitial Lung Disease in Mixed Connective Tissue Disease

    by Manuel Silvério-António, Joana Martins-Martinho, Ana Teresa Melo, Francisca Guimarães, Eduardo Dourado, Daniela Oliveira, Jorge Lopes, André Saraiva, Ana Gago, Margarida Correia, et al.

    Interstitial lung disease (ILD) frequently complicates mixed connective tissue disease (MCTD) and contributes to increased mortality. We aimed to identify predictors of ILD in MCTD patients. This is a nationwide, multicentre, retrospective study including patients with an adult-onset MCTD clinical diagnosis who met Sharp’s, Kasukawa, Alarcón-Segovia, or Kahn’s diagnostic criteria and had available chest high-resolution computed tomography (HRCT) data. Univariate and multivariate analyses were conducted. We included 57 MCTD patients, with 27 (47.4%) having ILD. Among ILD patients, 48.1% were asymptomatic, 80.0% exhibited a restrictive pattern on pulmonary function tests, and 81.5% had nonspecific interstitial pneumonia on chest HRCT. Gastroesophageal involvement (40.7% vs. 16.7%, p = 0.043) and lymphadenopathy at disease onset (22.2% vs. 3.3%, p = 0.045) were associated with ILD. Binary logistic regression identified lymphadenopathy at disease onset (OR 19.65, 95% CI: 1.91–201.75, p = 0.012) and older age at diagnosis (OR 1.06/year, 95% CI: 1.00–1.12, p = 0.046) as independent ILD predictors, regardless of gender and gastroesophageal involvement. This study is the first to assess a Portuguese MCTD cohort. As previously reported, it confirmed the link between gastroesophageal involvement and ILD in MCTD patients. Additionally, it established that lymphadenopathy at disease onset and older age at diagnosis independently predict ILD in MCTD patients.


  • Mechanic’s hands are associated with interstitial lung disease in myositis patients regardless of the presence of antisynthetase antibodies

    by Matilde Bandeira, Eduardo Dourado, Ana T Melo, Patrícia Martins, Vanessa Fraga, José L Ferraro, André Saraiva, Marlene Sousa, Hugo Parente, Catarina Soares, et al.

    Matilde Bandeira, Eduardo Dourado, Ana T Melo, Patrícia Martins, Vanessa Fraga, José L Ferraro, André Saraiva, Marlene Sousa, Hugo Parente, Catarina Soares, Ana


  • Focal facial myositis—a paraneoplastic syndrome?

    by Tiago Miguel Brandão de Melo Beirão, Beatriz Samões, Diogo Fonseca, Catarina Rua, Flávio Costa, Romana Vieira, Joana Aleixo, Taciana Videira, Cristina Ferreira, Henrique Coelho, et al.

    Tiago Beirão, Beatriz Samões, Diogo Fonseca, Catarina Rua, Flávio Costa, Romana Vieira, Joana Aleixo, Taciana Videira, Cristina Ferreira, Henrique Coelho, Patrí


  • Open Access

    Creation and Validation of a Portuguese Version of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument

    by Pedro L. Ferreira, Inês Genrinho, Tânia Santiago, Adriana Carones, Carolina Mazeda, Anabela Barcelos, Tiago Beirão, Flávio Costa, Inês Santos, Maura Couto, et al.

    (1) Background: The UCLA GIT 2.0 questionnaire has been recognized as a feasible and reliable instrument to assess gastrointestinal (GI) symptoms in systemic sclerosis (SSc) patients and their impact on quality of life. The aim of this study was to create and validate UCLA GIT 2.0 for Portuguese patients with SSc. (2) Methods: A multi-center study was conducted enrolling SSc patients. UCLA GIT 2.0 was validated in Portuguese using reliability (internal consistency, item –total correlation, and reproducibility) and validity (content, construct, and criterion) tests. Criterion tests included EQ-5D and SF-36v2. Social–demographic and clinical data were collected. (3) Results: 102 SSc patients were included, 82.4% of them female, and with a mean sample age of 57.0 ± 12.5 years old. The limited form of SSc was present in 62% of the patients and 56.9% had fewer than five years of disease duration. Almost 60% presented with SSc-GI involvement with a negative impact on quality of life. The means for SF-36v2 were 39.3 ± 10.3 in the physical component summary and 47.5 ± 12.1 in the mental component summary. Total GI score, reported as mild in 57.8% of the patients, was highly reliable (ICC = 0.912) and the Cronbach’s alpha was 0.954. There was a high correlation between the total GI score and EQ-5D-5L and SF-36v2 scores. (4) Conclusion: The Portuguese version of UCLA GIT 2.0 showed good psychometric properties and can be used in research and clinical practice.


  • Open Access

    A Rare Cause of Low Back Pain: A Challenging Diagnosis

    by Tiago Beirão, Jorge Reis, Joana Cochicho, Francisca Costa, Luís Malheiro, Taciana Videira, Joana Pimenta

    One of the rarest causes of low back pain is septic arthritis of a lumbar facet joint. We report the case of a 92-year-old diabetic woman with a history of four days of back pain, dysuria, and fever. Due to a sudden worsening of lumbar pain, she went to the emergency department. Physical exam revealed pain with pressure over the D12 vertebral apophyses and the lower-left paraspinal musculature. Laboratory data showed a normochromic normocytic anemia with a hemoglobin of 9.3 g/dL, white cell count of 14.61x10e3/µL (83.1% neutrophils), serum creatinine 1.46 mg/dL and C-reactive protein of 32.11 mg/dL. In urinalysis, nitrites and leukocyturia were identified. CT scan showed an acute D12 fracture and fat stranding at L5, with no irregularities in the discs or in other lumbar spaces. Escherichia coli was isolated in blood culture. Lumbar MRI confirmed the diagnosis of septic arthritis of an L5-S1 facet joint and L5 vertebrae osteomyelitis. The patient was successfully treated with intravenous ceftriaxone for eight weeks. As far as we know, this is the second report of septic arthritis of the facet joint caused by Escherichia coli.